Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis

Objective Microvascular invasion is shown to be an independent risk factor for liver cancer recurrence. Timely treatment may reduce the recurrence rate and prolong total survival time. The aim of this study was to investigate the effectiveness of sorafenib in treating patients with hepatocellular ca...

Full description

Bibliographic Details
Main Authors: Wang Gu, Zhong Tong
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060520946872